Starving brain tumors: diet and diabetes drug trial offers new hope
NCT ID NCT04691960
Summary
This study is testing whether a special high-fat, low-carbohydrate diet (ketogenic diet) combined with the diabetes medication metformin can help control aggressive brain tumors called glioblastomas. The approach aims to lower blood sugar levels, which might slow tumor growth. Researchers are checking if patients can tolerate and stick to this combined treatment plan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University
New York, New York, 10032, United States
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.